Identification of an Allosteric Binding Site on Human Lysosomal Alpha-Galactosidase Opens the Way to New Pharmacological Chaperones for Fabry Disease
Valentina Citro(University of Naples Federico II), Giuseppina Andreotti(National Research Council), Horacio Pérez‐Sánchez(Universidad Católica de Murcia), Jan Lukáš(University of Rostock), Ludovica Liguori(Istituto di Chimica Biomolecolare), Chiara Cimmaruta(Istituto di Chimica Biomolecolare), Jorge Peña‐García(Universidad Católica de Murcia), Helena den-Haan(Universidad Católica de Murcia), Rosita Del Prete(Toscana Life Sciences), Maria Vittoria Cubellis(Federico II University Hospital)
Cited by 31
Related Papers
MCC950 closes the active conformation of NLRP3 to an inactive state
|Nature Chemical Biology|2019|446
Receptor‐mediated internalization and degradation of urokinase is caused by its specific inhibitor PAI‐1.
|The EMBO Journal|1990|376
Neural network and deep-learning algorithms used in QSAR studies: merits and drawbacks
|Drug Discovery Today|2018|224
A Comprehensive Docking and MM/GBSA Rescoring Study of Ligand Recognition upon Binding Antithrombin
|Current Topics in Medicinal Chemistry|2017|193
High-Throughput parallel blind Virtual Screening using BINDSURF
|BMC Bioinformatics|2012|190